NASDAQ$BCYC

Bicycle Therapeutics plc · Q2 2019 earnings

Q2 2019 earnings · · Investor relations

Headline financials

Total Revenue

$1.52M

Previous: $1.66M-8.4%
EPS (adj)

-$1.40

Previous: -$0.37-273.8%
Capital Expenditures

-$881K

No prior period
Free Cash Flow

-$11.1M

No prior period
Net Income

-$10.2M

Previous: -$4.98M-105.2%
Operating Income

-$7.99M

Previous: -$4.96M-61.1%

Revenue & EPS history

Bicycle · Revenue · Quarterly

$1.52M

Q2 2019-8.4%vs Q2 2018
Beat estimate in 3 of 9 quarters(33%)
ActualEstimate

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2019

Historical avgQ2 2019

+1.2%

Avg return

Earnings day

-1.6%

Avg return

5 days after

+0.1%

Avg return

30 days after

52%

14 / 27 earnings

Positive

+19.3%

Q4 2019

Best reaction

-10.8%

Q1 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-0.2%+3.6%-0.8%
Q4 2025-4.2%-13.9%+1.8%
Q3 2025+6.7%-16.0%-8.6%
Q1 2025+6.1%-13.6%-4.0%
Q4 2024-1.3%-2.5%-18.3%
Q3 2024-5.5%-2.2%-15.1%
Q2 2024-0.7%+2.1%-10.0%
Q1 2024+1.6%-4.6%-8.3%
Q4 2023+3.1%+9.5%+14.9%
Q3 2023+1.2%-0.7%-2.3%
Q2 2023+1.3%-2.8%-4.1%
Q1 2023-0.4%+2.5%+15.7%
Q4 2022-1.9%-5.5%-6.2%
Q3 2022-3.2%+0.8%+29.6%
Q2 2022+14.8%+17.7%+12.8%
Q1 2022-10.8%-22.6%-33.6%
Q4 2021-1.2%-9.7%-7.6%
Q3 2021+0.7%+2.5%-6.8%
Q2 2021+1.8%+2.3%+36.0%
Q1 2021+1.9%-1.3%-5.5%
Q4 2020+1.9%+2.0%+3.8%
Q3 2020-1.5%+3.1%+5.2%
Q2 2020-0.2%+0.0%+5.8%
Q1 2020+0.7%+6.6%+23.2%
Q4 2019+19.3%+1.5%-2.3%
Q3 2019-4.2%-7.7%-4.8%
Q2 2019+5.9%+5.4%-6.6%
Q1 2019
Q4 2018
Q3 2018
Q2 2018
Q1 2018
Q4 2017

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro